approved EB-1A
Statistical Programmer
Biostatistics · China · 2025-03-14
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Framework Evaluation
3 of 3 criteria metScholarly Articles (Met)
The petitioner authored 29 peer-reviewed journal articles contributing to advancements in biostatistics.
Judging (Met)
The petitioner completed at least 40 manuscript reviews for scientific journals in her field.
Original Contributions (Met)
Her research on health disparities and biomedical safety has been cited 557 times and utilized extensively by peers globally.
Why This Petition Was Approved
The case was approved based on meeting multiple EB-1A criteria, including 29 peer-reviewed journal articles and 557 citations from researchers in 46 countries. She demonstrated a high level of expertise by reviewing at least 40 manuscripts for scientific journals. Additionally, her research received significant funding from major U.S. government institutions like the NHLBI, NIA, and NIMH.
Evidence
Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Original Contributions
Reference Letters Independent
Evidence Submitted
- 29 peer-reviewed journal articles
- 557 citations across at least 46 countries (Google Scholar)
- Peer review of at least 40 manuscripts for scientific journals
- Top 1% citation ranking in biostatistics
- Grants from major national and international organizations
- Research focus on health disparities and healthcare inequities
Similar Cases
Others
Research and Development · China
WeGreened EB-1A approved
New York 438 days 2025-04-03
The petition was approved based on meeting at least three EB-1A criteria: authorship of 15 peer-reviewed journal articles, a significant citation record of 771 citations, and the completion of 27 peer reviews for professional journals. Additionally, the work was supported by prestigious funding from the NIH, NSF, and Pfizer.
Assistant Professor
Research and Development · China
WeGreened EB-1A approved
Illinois 7 days 2024-01-05
The approval was based on a strong record of 22 peer-reviewed journal articles (including 8 first-authored) and 392 citations, demonstrating significant influence. The petitioner also provided evidence of 15 peer-review assignments for highly acclaimed journals. His employment at a highly ranked, federally funded institution further evidenced his extraordinary ability.
Lecturer
Research and Development · Ethiopia
WeGreened EB-1A approved
65 days 2025-10-24
The petition was approved based on the petitioner's authorship of 36 peer-reviewed journal articles and 1,517 citations, placing him in the top 1% of his field. Additionally, he performed 26 peer reviews and served as a Ph.D. dissertation committee member, satisfying the criteria for judging, original contributions, and scholarly articles.
Assistant Professor
Research and Development · China
WeGreened EB-1A rfe approved
Georgia 575 days 2025-05-23
The petition was approved based on 20 peer-reviewed publications and 575 citations, placing the applicant in the top 1% of his field. Additionally, he demonstrated a significant record of 26 peer reviews for academic journals. His development of bioinformatics tools for single-cell RNA sequencing was recognized as a major original contribution.
Frequently Asked Questions
A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-03-14.
Browse all casesAt a Glance
Outcome approved
Processing 37 days
Criteria Met 3 / 3
Evidence Types 6
EB-1A Case Data
Scraped Case Data
Total Cases 919
Success Rate 53.0%
Sustained 487
Dismissed 315
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist